Nom du produit:2,3,5,6-Tetrafluoro-4-(methoxymethyl)benzyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate

IUPAC Name:[2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate

CAS:271241-14-6
Formule moléculaire:C19H22F4O3
Pureté:95%
Numéro de catalogue:CM184657
Poids moléculaire:374.38

Unité d'emballage Stock disponible Prix($) Quantité
CM184657-5g 3-4 Weeks ǭřƏ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:271241-14-6
Formule moléculaire:C19H22F4O3
Point de fusion:-
Code SMILES:O=C(C1C(C)(C)C1C=C(C)C)OCC2=C(F)C(F)=C(COC)C(F)=C2F
Densité:
Numéro de catalogue:CM184657
Poids moléculaire:374.38
Point d'ébullition:352.4°C at 760 mmHg
N° Mdl:MFCD09752840
Stockage:Store at 2-8°C.

Category Infos

Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.